UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial

Nature medicine, 2021-10, Vol.27 (10), p.1789-1796

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Journal for immunotherapy of cancer, 2016-10, Vol.4 (1), p.60-60, Article 60

2016

Link zum Volltext

Verfügbarkeit prüfen

Tandem Incorporation of Enantiomeric Residues Engenders Discrete Peptoid Structures

Organic letters, 2016-06, Vol.18 (11), p.2780-2783

2016

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Functionalized Oxacalix[4]arenes

Organic letters, 2005-01, Vol.7 (1), p.91-94

2005

Link zum Volltext

Verfügbarkeit prüfen

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

Journal of the American Academy of Dermatology, 2012-12, Vol.67 (6), p.1375-1379

2012

Link zum Volltext

Verfügbarkeit prüfen

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of oncology, 2015-11, Vol.26 (11), p.2267-2274

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Annals of oncology, 2015-07, Vol.26 (7), p.1481-1487

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Oxacalixarenes Incorporating Nitrogen Heterocycles: Evidence for Thermodynamic Control

Organic letters, 2006-06, Vol.8 (13), p.2755-2758

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Annals of oncology, 2018-10, Vol.29, p.viii736-viii736

2018

Link zum Volltext

Verfügbarkeit prüfen

Application of H/D Exchange to Hydrogen Bonding in Small Molecules

Chemistry : a European journal, 2013-11, Vol.19 (45), p.15101-15104

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathological complete response after neoadjuvant pembrolizumab and radiation

Clinical and experimental dermatology, 2019-07, Vol.44 (5), p.570-573

2019

Link zum Volltext

Verfügbarkeit prüfen

Concomitant conformational dimorphism in 1,2-bis(9-anthryl)acetylene

CrystEngComm, 2015-01, Vol.17 (26), p.4877-4882

2015

Link zum Volltext

Verfügbarkeit prüfen

Electronic Structure Studies of Oxomolybdenum Tetrathiolate Complexes: Origin of Reduction Potential Differences and Relationship to Cysteine−Molybdenum Bonding in Sulfite Oxidase

Inorganic chemistry, 2000-12, Vol.39 (25), p.5697-5706

2000

Link zum Volltext

Verfügbarkeit prüfen

Spectroscopic and electrochemical properties of di-2-thienyl ketone thiosemicarbazone (dtktsc): electrochemical reactions with electrophiles (H+ and CO2)

Electrochimica acta, 2016-09, Vol.212, p.1010-1020

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a messenger RNA polynucleotide vaccine vector

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (7), p.1397-1400

1995

Link zum Volltext

Verfügbarkeit prüfen

X-ray crystallographic, spectroscopic, and electrochemical properties of Group 12 metal-chlorides of di-2-pyridyl ketone acetic acid hydrazone (dpkaah)

Journal of coordination chemistry, 2018-08, Vol.71 (15), p.2322-2339

2018

Link zum Volltext

Verfügbarkeit prüfen

Spectroscopic, electrochemical and X-ray crystallographic properties of a novel palladium(II) complex of thioamide deprotonated di-2-pyridyl ketone thiosemicarbazone (dpktsc-H)

Journal of coordination chemistry, 2017-09, Vol.70 (17), p.3048-3064

2017

Link zum Volltext

Verfügbarkeit prüfen

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Clinical cancer research, 2000-01, Vol.6 (1), p.34-41

2000

Link zum Volltext

Verfügbarkeit prüfen

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

The New England journal of medicine, 2011-06, Vol.364 (26), p.2507-2516

2011

Link zum Volltext

Verfügbarkeit prüfen

LBA39 Final 5-year results of the phase II, multicenter, randomized, open-label trial of talimogene laherparepvec (T-VEC) neoadjuvant treatment (Tx) plus surgery vs immediate surgery in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL)

Annals of oncology, 2022-09, Vol.33, p.S1406

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Clinical cancer research, 1999-09, Vol.5 (9), p.2330-2337

1999

Link zum Volltext

Verfügbarkeit prüfen

Single-step synthesis of D3h-symmetric bicyclooxacalixarenes

Organic letters, 2005-08, Vol.7 (16), p.3505-3507

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Vaccine, 2004-01, Vol.22 (5-6), p.773-780

2004

Link zum Volltext

Verfügbarkeit prüfen

Selected strategies to augment polynucleotide immunization

Gene therapy, 1996-01, Vol.3 (1), p.67

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(231)

Publikationsform

Sprache

Englisch
(274)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Tandem Incorporation of Enantiomeric Residues Engenders Discrete Peptoid Structures

Synthesis of Functionalized Oxacalix[4]arenes

Nonmalignant cutaneous findings associated with vemurafenib use in patients with metastatic melanoma

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors

Synthesis of Oxacalixarenes Incorporating Nitrogen Heterocycles: Evidence for Thermodynamic Control

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy

Application of H/D Exchange to Hydrogen Bonding in Small Molecules

Pathological complete response after neoadjuvant pembrolizumab and radiation

Concomitant conformational dimorphism in 1,2-bis(9-anthryl)acetylene

Electronic Structure Studies of Oxomolybdenum Tetrathiolate Complexes: Origin of Reduction Potential Differences and Relationship to Cysteine−Molybdenum Bonding in Sulfite Oxidase

Spectroscopic and electrochemical properties of di-2-thienyl ketone thiosemicarbazone (dtktsc): electrochemical reactions with electrophiles (H+ and CO2)

Characterization of a messenger RNA polynucleotide vaccine vector

X-ray crystallographic, spectroscopic, and electrochemical properties of Group 12 metal-chlorides of di-2-pyridyl ketone acetic acid hydrazone (dpkaah)

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Spectroscopic, electrochemical and X-ray crystallographic properties of a novel palladium(II) complex of thioamide deprotonated di-2-pyridyl ketone thiosemicarbazone (dpktsc-H)

Human Autoantibodies to Carcinoembryonic Antigen (CEA) Induced by a Vaccinia-CEA Vaccine

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

LBA39 Final 5-year results of the phase II, multicenter, randomized, open-label trial of talimogene laherparepvec (T-VEC) neoadjuvant treatment (Tx) plus surgery vs immediate surgery in patients (pts) with resectable stage IIIB-IVM1a melanoma (MEL)

Phase I Trial of a Recombinant Vaccinia Virus Encoding Carcinoembryonic Antigen in Metastatic Adenocarcinoma: Comparison of Intradermal versus Subcutaneous Administration

Single-step synthesis of D3h-symmetric bicyclooxacalixarenes

Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor

Selected strategies to augment polynucleotide immunization

Suchergebnisse filtern